StreetonD.H.P.Corticosteroid therapy: Pharmacological properties and principles of corticosteroid use. JAMA1975; 232: 944–7.
2.
WilliamsG.H., DluhyR.G.Diseases of the adrenal cortex, in Harrison's Principles of Internal Medicine, 13th ed. New York, McGraw-Hill, 1994; 1953–76.
3.
WilsonJ.D., FosterD.W. (eds): Williams Textbook of Endocrinology, 8th ed. Philadelphia, WB Saunders, 1992.
4.
MelbyJ.C.Systemic corticosteroid therapy: Pharmacology and endocrinologic considerations. Ann Intern Med1974; 81: 505–12.
5.
HallE.D.Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury. Cell Molec Neurobiol1993; 13: 415–32.
6.
McEvoyG.K. (ed): AHFS Drug Information 1995.Bethesda, MD, American Society of Health-System Pharmacists, 1995.
7.
GilmanA.G. (eds): Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 6th ed. New York, Macmillan, 1980.
8.
LaanR.Vertebral osteoporosis in rheumatoid arthritis patients: Effects of low dose prednisone therapy. Br J Rheumatol1992; 31: 91–6.
9.
JohnstonC.C., SlemendaC.W., MeltooL.J.Clinical use of bone densitometry. N Engl J Med1991; 24: 1105–9.
10.
WhitworthJ.A.Adrenocorticotrophin and steroid-induced hypertension in humans. Kidney Int1992; 41(suppl 37): 34–7.
11.
DekhuijzenP.N.R., DecramerM.Steroid-induced myopathy and its significance to respiratory disease: A known disease rediscovered. Eur Respir J1992; 5: 997–1003.
12.
RenfroL., SnowJ.S.Ocular effects of topical and systemic steroids. Dermatol Clin1992; 10: 505–12.
13.
AllenM.B., RayS.G., LeitchA.G.Steroid aerosols and cataract formation. Br Med J1989; 299: 432.
14.
CoombsR.R.H., ThomasR.Avascular necrosis of the hip. Brit J Hosp Med1994; 51: 275–80.
15.
DesforgesJ.Current concepts in osteonecrosis. N Engl J Med1991; 22: 1473.
16.
KennedyD.W. Personal communication, June 1995.
17.
MabryR.Corticosteroids in rhinology, in Goldman (ed): The Principles and Practice of Rhinology.New York, John Wiley, 1987.
18.
DereberyM.Otolaryngic allergy. Oto Clin N Am1993; 26: 593–611.
19.
HarterJ.G., ReddyW.J., ThornG.W.Studies on an intermittent corticosteroid dosage regimen. N Engl J Med1963; 269: 591.
20.
WebbD.R.Steroids in allergic disease. Med Clin N Am1981; 65: 1073–81.
21.
SalassaR.M., BennetW.A., KeatingF.R.Postoperative adrenal cortical insufficiency; occurrence in patients previously treated with cortisone. JAMA1953; 152: 1509–15.
22.
FeelyJ.Drugs and the endocrine system, in Wood, and Wood (eds): Drugs and Anesthesia: Pharmacology for Anesthesiologists.Baltimore, Williams and Wilkins Co., 1982; 604–7.
23.
MichelsM.I., SmithR.E., HeimlichE.M.Adrenal suppression and intranasally applied steroids. Ann Allergy1967; 25: 569–74.
24.
KatzensteinA-L, SaleS.R., GreenbergerP.A.Allergic aspergillus sinusitis: A newly recognized form of sinusitis. J Allergy Clin Immunol1983; 72: 89–93.
25.
SafirsteinB., D'SouzaM., SimonG.Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis1973; 108: 450–9.
26.
BentJ.P., KuhnF.A.Diagnosis of allergic fungal sinusitis. Oto HNS1994; 111: 580–8.
WaxmanJ.E., SpectorJ.G., SaleS.R.Allergic aspergillus sinusitis: Concepts in diagnosis and treatment of a new clinical entity. Laryngoscope1987; 97: 261–6.
29.
AllphinA.L., StraussM., Abdul-KarimF.W.Allergic fungal sinusitis: Problems in diagnosis and treatment. Laryngoscope1991; 101: 815–20.
30.
TavernerD.Cortisone treatment of Bell's palsy. Lancet1954; 2: 1052–6.
31.
StankiewiczJ.A.Steroids and idiopathic facial paralysis. Oto HNS1983; 91: 672–7.
32.
StankiewiczJ.A.A review of the published data on steroids and idiopathic facial paralysis. Oto HNS1987; 97: 481–6.
33.
WolfS.M.Treatment of Bell's palsy with prednisone: A prospective randomized study. Neurology1978; 28: 158–61.
34.
AustinJ.R., PeskindS.P., AustinS.G.Idiopathic facial nerve paralysis: A randomized double blind controlled study of placebo versus prednisone. Laryngoscope1993; 103: 1326–33.
35.
HughesG.B.Practical management of Bell's palsy. Oto HNS1990; 102: 658–63.
36.
AdourK.Corticosteroid therapy for acute facial paralysis, in SnowJ. (ed): Controversies in Otolaryngology.Philadelphia, WB Saunders, 1980; 395–400.
37.
NeelyJ.G.Idiopathic facial paralysis, in GatesG.A. (ed): Current Therapy in Otolaryngology—Head and Neck Surgery, 1982-3.St. Louis, Mosby, 1982; 73–6.
38.
GatesG.A. Personal communication, February 1995.
39.
GrandisJ.R., HirschB.E., WagenerM.M.Treatment of idiopathic sudden sensorineural hearing loss. Am J Otol1993; 14: 183–5.
40.
WilsonW.R., BylF.M., LairdN.Efficacy of steroids in the treatment of idiopathic sudden hearing loss: A double-bind clinical study. Arch Otolaryngol1980; 106: 772–6.
41.
MoskowitzD.Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope1984; 94: 664–6.
42.
McCabeB.F.Autoimmune ear disease: Therapy. Am J Otol1989; 10: 196–7.
43.
SheaJ.J.Autoimmune sensorineural hearing loss as an aggravating factor in Meniere's disease. Adv Otorhinolaryngol1983; 30: 254–7.
44.
SuzukiM., KitaharaM.Immunologic abnormality in Meniere's disease. Oto HNS1992; 107: 57–62.
45.
McCabeB.F.Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol1979; 88: 585–9.
46.
AtkinsonJ.P.Diagnosis and management of hereditary angioedema. Ann Allergy1979; 42: 348–52.
47.
HawkinsD.B.Corticosteroids in the management of laryngotracheo-bronchitis. Otorhinolaryngol Head Neck Surg1980; 88: 207–10.
48.
HawkinsD.B., ShumT.K., CrockettD.M.Corticosteroids in otolaryngology, in CollinsS. (ed): Pharmacology in Otolaryngology—Head and Neck Surgery.Washington, DC, American Academy of Otolaryngology—Head and Neck Surgery Foundation, Inc., 1987; 30–50.
49.
KorenG.Corticosteroid treatment of laryngotracheitis versus spasmodic croup in children. Am J Dis Child1983; 137: 941.
CatlinF.I., GrimesW.J.The effect of steroid therapy on recovery from tonsillectomy in children. Arch Oto HNS1991; 117: 649–52.
52.
VolkM.S., MartinP., BrodskyL.The effects of preoperative steroids on tonsillectomy patients. Oto HNS1993; 109: 726–30.
53.
HolingerL.D., TuckerG.F. In Cummings (eds): Trauma, in Otolaryngology—Head and Neck Surgery, 2nd ed. St. Louis, Mosby Year Book, 1993.
54.
HawkinsD.B., DemeterM.J., BarnettT.E.Caustic ingestion: Controversies in management. Laryngoscope1980; 90: 98–109.
55.
WaldE.R., KaplanS.L., MasonE.O.Dexamethasone therapy for children with bacterial meningitis. Pediatrics1995; 95: 21–32.
56.
OdioC.M., FaingezichtI., ParisM.The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med1991; 324: 1525–31.
57.
Dexamethasone therapy for bacterial meningitis in infants and children, in Report of the Committee on Infectious Diseases of the American Academy of Pediatrics, 23rd ed. Elk Grove Village, IL, American Academy of Pediatrics, 1994; 558–9.